BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21814547)

  • 1. TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program.
    McCaffery JM; Jablonski KA; Franks PW; Dagogo-Jack S; Wing RR; Knowler WC; Delahanty L; Dabelea D; Hamman R; Shuldiner AR; Florez JC;
    PLoS One; 2011; 6(7):e21518. PubMed ID: 21814547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of TCF7L2 SNPs with age at onset of type 2 diabetes and proinsulin/insulin ratio but not with glucagon-like peptide 1.
    Silbernagel G; Renner W; Grammer TB; Hügl SR; Bertram J; Kleber ME; Hoffmann MM; Winkelmann BR; März W; Boehm BO
    Diabetes Metab Res Rev; 2011 Jul; 27(5):499-505. PubMed ID: 21384500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population.
    González-Sánchez JL; Martínez-Larrad MT; Zabena C; Pérez-Barba M; Serrano-Ríos M
    Diabetologia; 2008 Nov; 51(11):1993-7. PubMed ID: 18712344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCF7L2 is a master regulator of insulin production and processing.
    Zhou Y; Park SY; Su J; Bailey K; Ottosson-Laakso E; Shcherbina L; Oskolkov N; Zhang E; Thevenin T; Fadista J; Bennet H; Vikman P; Wierup N; Fex M; Rung J; Wollheim C; Nobrega M; Renström E; Groop L; Hansson O
    Hum Mol Genet; 2014 Dec; 23(24):6419-31. PubMed ID: 25015099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of common variants of
    Basu J; Mukherjee R; Sahu P; Datta C; Chowdhury S; Mandal D; Ghosh A
    Nucleosides Nucleotides Nucleic Acids; 2024; 43(3):185-202. PubMed ID: 37610142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study.
    Stolerman ES; Manning AK; McAteer JB; Fox CS; Dupuis J; Meigs JB; Florez JC
    Diabetologia; 2009 Apr; 52(4):614-20. PubMed ID: 19183934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population.
    Loos RJ; Franks PW; Francis RW; Barroso I; Gribble FM; Savage DB; Ong KK; O'Rahilly S; Wareham NJ
    Diabetes; 2007 Jul; 56(7):1943-7. PubMed ID: 17416797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with impaired proinsulin conversion--A meta-analysis.
    Shen J; Fang Y; Ge W
    Diabetes Res Clin Pract; 2015 Jul; 109(1):117-23. PubMed ID: 25934528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test.
    Gjesing AP; Kjems LL; Vestmar MA; Grarup N; Linneberg A; Deacon CF; Holst JJ; Pedersen O; Hansen T
    Diabetologia; 2011 Jan; 54(1):103-10. PubMed ID: 20957343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between TCF7L2 gene polymorphism and genetic susceptibility in women with gestational diabetes mellitus].
    Shi X; Cai Q; Zou M; Shen Y
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):588-93. PubMed ID: 25354859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population.
    Zheng X; Ren W; Zhang S; Liu J; Li S; Li J; Yang P; He J; Su S; Li P
    Mol Biol Rep; 2012 Jan; 39(1):17-23. PubMed ID: 21437630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rs7903146 Variant in the
    Cropano C; Santoro N; Groop L; Dalla Man C; Cobelli C; Galderisi A; Kursawe R; Pierpont B; Goffredo M; Caprio S
    Diabetes Care; 2017 Aug; 40(8):1082-1089. PubMed ID: 28611053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The T-allele of TCF7L2 rs7903146 associates with a reduced compensation of insulin secretion for insulin resistance induced by 9 days of bed rest.
    Alibegovic AC; Sonne MP; Højbjerre L; Hansen T; Pedersen O; van Hall G; Holst JJ; Stallknecht B; Dela F; Vaag A
    Diabetes; 2010 Apr; 59(4):836-43. PubMed ID: 20107109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma metabolomics reveal alterations of sphingo- and glycerophospholipid levels in non-diabetic carriers of the transcription factor 7-like 2 polymorphism rs7903146.
    Then C; Wahl S; Kirchhofer A; Grallert H; Krug S; Kastenmüller G; Römisch-Margl W; Claussnitzer M; Illig T; Heier M; Meisinger C; Adamski J; Thorand B; Huth C; Peters A; Prehn C; Heukamp I; Laumen H; Lechner A; Hauner H; Seissler J
    PLoS One; 2013; 8(10):e78430. PubMed ID: 24205231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in TCF7L2 rs7903146 and history of GDM negatively and independently impact on diabetes-associated metabolic traits.
    Fritsche L; Sarief M; Wagner R; Stefan N; Lehmann R; Häring HU; Grallert H; Fritsche A; Lechner A
    Diabetes Res Clin Pract; 2018 Dec; 146():251-257. PubMed ID: 30419301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationship of the rs7903146 TCF7L2 gene variant with measures of glucose metabolism and adiposity: The NEO study.
    Noordam R; Zwetsloot CPA; de Mutsert R; Mook-Kanamori DO; Lamb HJ; de Roos A; de Koning EJP; Rosendaal FR; Willems van Dijk K; van Heemst D
    Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):150-157. PubMed ID: 29174029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes.
    Dujic T; Bego T; Malenica M; Velija-Asimi Z; Ahlqvist E; Groop L; Pearson ER; Causevic A; Semiz S
    Bosn J Basic Med Sci; 2019 Nov; 19(4):368-374. PubMed ID: 31070566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of transcription factor 7 like 2 gene rs7903146 variation with type 2 diabetes and obesity related parameters.
    Kahveci C; Koldemir M; Cagatay P; Bayer H; Yildiz S; Bagriacik N; Duman BS
    Diabetes Metab Syndr; 2012; 6(1):48-53. PubMed ID: 23014255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.
    Florez JC; Jablonski KA; Bayley N; Pollin TI; de Bakker PI; Shuldiner AR; Knowler WC; Nathan DM; Altshuler D;
    N Engl J Med; 2006 Jul; 355(3):241-50. PubMed ID: 16855264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes.
    Haupt A; Thamer C; Heni M; Ketterer C; Machann J; Schick F; Machicao F; Stefan N; Claussen CD; Häring HU; Fritsche A; Staiger H
    Diabetes; 2010 Mar; 59(3):747-50. PubMed ID: 20028944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.